Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and related sections on the ClinicalTrials.gov page. This change affects how the page is accessed rather than the study information itself.SummaryDifference18%

- Check34 days agoChange DetectedThe page's revision label updated to v3.7.0, replacing the previous v3.6.6 in the version metadata.SummaryDifference0.0%

- Check41 days agoChange DetectedQiryat Krinitzi, Israel, 52621, was removed from the study's Israel locations. Tel Litwinsky, Israel, 52621, was added as a new site.SummaryDifference0.0%

- Check48 days agoChange DetectedThe participating sites list was updated to include Qiryat Krinitzi, Israel, 52621 and exclude Tel Litwinsky, Israel, 52621. The page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This reflects a new release of the site's revision or content management update.SummaryDifference0.0%

Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.